Analyzing gene expression patterns in genetic models of alcoholism may uncover previously unknown susceptibility genes, and point to novel targets for drug development. Here, we compared expression profiles in alcoholpreferring AA rats with the alcohol-avoiding counterpart ANA line, and unselected Wistar rats. Cingulate cortex, Nc. accumbens, amygdala and hippocampus of each line were analyzed using the Afymetrix RN U34 arrays and dChip 1.1 software. Analysis of line-specific expression revealed 48 differentially expressed genes between AA and ANA rats. Elevated hippocampal neuropeptide Y (NPY) was found in ANA rats in agreement with previous studies. A cluster of MAP-kinases indicating altered signal transduction was upregulated within the Nc. Accumbens of the AA line, and is of particular functional interest. Within the amygdala, a more loosely inter-related cluster of cytoskeleton-associated genes may point to structural abnormalities. The observed dysregulations may contribute to the alcohol-preferring phenotype.
INTRODUCTION
Alcoholism is a multifactorial disease with an overall heritability estimated to 50-60%, the remaining variance being accounted for by nonshared environmental factors. A subgroup with particularly high heritability is composed of approximately one fourth of alcohol-dependent patients, characterized by early onset of alcohol problems, deficient impulse control and pronounced positively reinforcing effects of alcohol. On the basis of their functional role, several candidate genes have been suggested to confer genetic susceptibility for alcoholism. Among these are monoaminergic genes involved in brain reward pathways and serotonergic genes involved in impulse control and anxiety traits (for review, see Enoch and Goldman 1 ). More recently, on the basis of animal studies, an involvement has been suggested for neuropeptide Y (NPY), 2 but human findings have been inconsistent, 3, 4 possibly due to the methodological difficulties involved, and due to the limited quantitative contribution of individual loci in the complex trait of alcoholism.
Models in experimental animals therefore offer a useful complement to human genetic studies. No single paradigm models the complex clinical syndrome of alcohol dependence, but models of clinically relevant traits are available, and have demonstrated a predictive validity. 5 One of the best established among these models is the alcohol-preferring AA rat line, 6 which has been bred for high alcohol consumption for-over 90 generations, and displays a stable phenotype of alcohol preference. Its genetic counterpart is the ANA (alcohol nonaccepting) rat line, which was bred for low alcohol consumption in parallel with the AA line. Besides its genetic preference for high ethanol drinking, the AA rat shows behavioral disinhibition. 7 Together with the high ethanol consumption, this rat line thus shares intermediate phenotypic traits with early-onset alcoholism. 1 Interestingly, these traits have cosegregated also when breeding the counterpart line for low alcohol preference, such that the ANAs display higher than normal behavioral suppression, with the phenotypic hierarchy for ethanol preference being AA4Wistar4 ANA, while the opposite is true for behavioral inhibition.
Analysis of mRNA expression profiles offers an attractive tool for studying interactions between genetic susceptibility factors and neuroadaptive processes in the development of alcohol dependence. In a previous study of the AA and ANA rats performed with differential display RT-PCR, 8 we were able to detect and confirm differential gene expression of two transcripts in the parietal cortex: the ribosomal protein L18A and diacylglycerol kinase iota (DGKI). The utility of the differential display strategy is, however, severely limited by its low throughput. Recent advances in DNA-microarray technology have markedly improved the feasibility of identifying differential gene expression patterns, and have been useful in identifying novel candidate genes in alcoholrelated neuroadaptations. 9, 10 Here, we therefore used oligonucleotide DNA-microarrays to compare profiles of gene expression in the forebrain of AA and ANA rats. Nonselected Wistar rats were initially also included in the analysis, since they quantitatively represent a behavioral phenotype that falls between the two selected lines both with regard to alcohol preference and anxiety. Based on available knowledge of brain reward pathways and key areas involved in the regulation of ethanol intake, 11 we analysed cingulate cortex, amygdala, accumbens and hippocampus.
RESULTS
After quality assessment, 32 out of 36 chips (eight per region) were included into the quantitative expression analysis. Chipwise expression estimates and the probability of detection for each probe set are available from the author on request. The initial evaluation focused on the specificity and sensitivity of the microarray analysis. Figure 1 demonstrates Figure 1 This radial dendrogram displays the differences between gene expression profiles of the samples. The centroid represents the average profile over all samples. Samples from different brain regions form separate clusters. Also, expression patterns in the cingulate cortex visualise the genetic relationship between the lines resulting from the breeding program: that is, AA and ANA coming from the same parental strain (Brown Norway), while the Wistar strain has been used at a later stage of the breeding to revitalise the AA and ANA lines. In the other brain regions, the genetic relationship between lines does not emerge as clearly. The dendrogram was obtained via the Neighbor-Joining option in the Phylip program and the radial option in the TreeView program. 39 The distance data for the dendrogram were the 'Manhattan' distances between gene expression profiles. Only genes called 'Present' (see Materials and Methods) in at least half the samples were used. Sample labeling is as follows: region (Acc, Amy, CCx, Hip for amygdala, accumbens, cingulate cortex and hippocampus, respectively), strain (AA, ANA and Wistar) and an individual number of the sample.
that the GeneChip-generated expression profiles form, as expected, clusters according to brain region. The differences between the lines are most clearly reflected in the dendrogram for the cingulate cortex. This visualizes that, despite their divergence of alcohol preference, AA and ANA are closer to each other than to the nonselected Wistar line, presumably reflecting that they were originally selected from a common parental strain, which was different from the Wistar line.
We also assessed regionally highly enriched gene expression independent of line effects. A total of 688 probe sets, that is 52% of the probe sets present on the RN34U arrays, fulfilled the criteria for detection ('present-call'; for criteria definition, see Method section) in at least one of the brain regions. Only 17 probe sets were found to be present in a single region and absent in all others. Of these, five genes had signals clearly distinguishable from background and their expression was classified as region specific. In addition, nine genes showed highly enriched expression in a particular region. Expression patterns for most of these genes are well described in the literature and fully concordant with the present analysis ( Table 1) .
We statistically evaluated differences in regional gene expression only between the genetically related AA and ANA lines. In total, 48 genes were differentially expressed between the AA and ANA lines, with the number of differentially expressed genes varying between 11 and 18 per region. The nucleus (Nc.) Accumbens appeared to be the most divergent region.
Functional clustering of differentially expressed genes suggested two subgroups: those involved in signal transduction most prominently in the accumbens, and cytoskeletonassociated genes in the amygdala (Figure 2) . Tables 2-5 give the expression estimates and t-statistics for amygdala, accumbens, cingulate cortex and hippocampus, respectively. Notably, fold change differences are generally below twofold. Only a few genes are flagged in more than one region. To elucidate if the pressure of genetic selection has acted at specific regions of the rat genome, we analysed the genomic distribution of loci giving rise to gene expression differences ( Figure 3 ). No particular chromosome or chromosomal region appears to be predominantly affected.
Owing to the availability of prior data, 12 and the fact that NPY was flagged as differentially expressed within the hippocampus, real-time RT-PCR was performed to obtain relative mRNA levels for NPY gene expression in this region. After normalisation to cyclophilin, a significant difference (approx. 20%) was obtained between the AA and ANA lines in preproNPY mRNA levels (F(1,14) ¼ 5.49, Po0.05).
Since b-arrestin 2 had consistently lower expression levels in three of four regions of the AA line we developed a realtime RT-PCR assay and compared relative mRNA levels for this gene in the hippocampus. After normalization to cyclophilin, we confirmed significantly lower b-arrestin expression in the hippocampus (approx. 15%, F(1,14) ¼ 4.81, Po0.05). There were no differences in cyclophilin A gene expression between the lines (F(1,14) ¼ 0.397, P ¼ 0.54 and F(1,14) ¼ 0.211, P ¼ 0.65 for the NPY and b-arrestin assays, respectively). Similar results for NPY and b-arrestin have been obtained using b-actin gene expression for normalization (data not shown).
DISCUSSION
Compared to a prior attempt by our group, 8 the application of GeneChip technology appears to offer an advantageous strategy for identifying genes potentially underlying phenotypic differences between the alcohol-preferring AA and dChip estimates (mean7SEM) from four forebrain regions were calculated using eight chips per region, with pooled material from three subjects on each chip. Rat line effects were neglected in this analysis. Bold letters mark the region with restricted or highly enriched gene expression. For criteria of restricted and highly enriched gene expression see the Materials and method section. The present findings are in concordance with available in situ mapping studies cited.
Expression profiling in AA and ANA rats C Arlinde et al the avoiding ANA lines. An initial indication of this methodology's ability to identify differentially expressed genes correctly was provided by the analysis of region-specific expression in the brain areas examined. To our knowledge, data for regional patterns of gene expression in the mammalian brain have previously only been available in the mouse. 13 Our analysis in the rat correctly identified a limited set of genes known to be preferentially expressed within the Nc. Accumbens, including dopamine D1 and D2 receptors, substance P (tachykinin 1) and adenosin A2A receptors. A further degree of confirmation was provided by the preproNPY expression results. Here, the GeneChip data on relative hippocampal expression between the lines were in close agreement with results previously obtained in our laboratory using in situ hybridization, 15 and were subsequently possible to further confirm using quantitative realtime PCR. This finding per se is not likely to account for the alcohol-preferring phenotype of the AA line, since NPY expression does not differ between this line and Wistars. However, the upregulated expression in nonpreferring ANA rats could reflect a protective effect of potentiated NPY signaling, in agreement with previous findings. 2 More importantly, however, the close correlation of the GeneChip data with quantitation obtained using two other independent methods provides a validation of the array analysis, despite difficulties inherent in analyzing differential gene expression in heterogeneous tissues.
When gene expression profiles were compared between the lines, only modest differences in transcript levels were detected. Since regions known to be involved in the control of alcohol intake were analysed, this indicates that changes of this magnitude, although perhaps involving numerous genes, are sufficient to encode phenotypic differences known to exist between the lines. This finding is in agreement with earlier reports on brain expression profiles associated with ethanol preference and consumption in humans and rodents. [8] [9] [10] 14, 15 Interestingly, the Nc. Accumbens, a key component of brain reward systems, showed the highest divergence of gene expression among the regions examined.
The array analysis indicated that b-arrestin is robustly downregulated in the Nc. Accumbens, amygdala and hippocampus of the AA line. This gene is a key component of receptor trafficking, by forming complexes with activated G-protein-coupled receptors, leading to their uncoupling and sequestration/recycling via endocytosis into clathrincoated vesicles. 16 This mechanism has been demonstrated for the alpha1b-and beta2-adrenergic receptors, muand delta-opioid receptors, the dopamine D1 receptor Figure 2 Functional clustering of genes differentially expressed between AA and ANA rats. In all, 13 genes involved in signal transduction form the most prominent cluster. The broken outer ring gives cluster distribution in percent of the total number of genes (n ¼ 48) identified in the microarray analysis. The numbers in the inner circles correspond to the distribution within a brain region and are given in percent of the number of genes flagged in that region (Acc: Nc. accumbens n ¼ 18; Amy: amygdala n ¼ 11; CCx cingulate cortex n ¼ 13; Hip: hippocampus n ¼ 15). For clusters containing only a single member, no percentage values are given.
Expression profiling in AA and ANA rats C Arlinde et al and cannabinoid CB1 receptor. 17, 18 Upon ligand binding b-arrestin also recruits cAMP phosphodiesterase type IV to the recetor-adenylate cyclase complex. 19 Both mechanisms lead to receptor desensitization and cAP signal termination. Consequently, b-arrestin downregulation may produce an increased responsiveness in several neurotransmitter systems and thus might offer a mechanism for the reported increased opiate and dopamine responsiveness in the AA line. [20] [21] [22] An involvement of b-arrestin in morphine tolerance has been reported. 23 Interestingly, an overexpression of b-arrestin in the amygdala was found in our earlier microarray study of ethanol-exposed rats. 9 Further, we found several members of the MAPK pathways to be upregulated in the AA Nc. Accumbens. This could be secondary to increased receptor signaling due to low b-arrestin. Mitogen-activated protein kinases (MAP kinases), also called extracellular signal-regulated protein kinases (ERKs), form a three-level network of proteins that, through successive phosphorylation steps, transduces extracellular signals into cytoplasmic and ultimately nuclear events. 24 The upregulated MAPK pathway in AA rats may thus reflect altered signal transduction upon activation of upstream receptors. Several neurotransmitter receptors, including NMDA, beta-2-adrenergic and CB1 receptors, can induce MAPK and stress-activated protein kinase (SAPK) MAPK cascades. [25] [26] [27] [28] We have previously reported that this pathway is activated in the cingulate cortex of another animal model characterized by persistently increased voluntary ethanol consumption and preference. 9 One of the genes detected in that model, Mapk9, was also upregulated in the Data represent expression estimates (mean7SEM) from individual arrays (n ¼ 3/strain) analysed by dChip software as described in the Materials and method section. Linear fold changes (FC), P-values, and 90% lower and upper confidence bounds (LCB and UCB, respectively) refer to AA vs ANA comparison. Positive or negative FC refer to up-or downregulation in AA, respectively. p-values result from individual t-tests (AA vs. ANA) for each gene. Only genes meeting the following filtering criteria are shown: (1) Po0.05, (2) UCB471.1, and (3) reliable detection on at least half of the arrays region. Gene symbols are assigned according to annotation of the respective mouse orthologs using the Ensembl Genome Browser. Same clusters as in Figure 2 are used.
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Expression profiling in AA and ANA rats C Arlinde et al cingulate cortex of AA animals in the present study. A potential functional relevance of these changes is underlined by recent functional findings that ERK activity is regulated in the rat brain by chronic ethanol exposure and withdrawal. Chronically elevated blood alcohol levels were reported to reduce activity of ERK, whereas activity rose during the withdrawal state. These findings were most pronounced in the amygdala and in particular in the intermittent model of ethanol exposure. 29 In the amygdala, we found a cluster of downregulated genes related to cytoskeleton and tissue structure. Among these, the microtubule-associated protein 2 (Mtap2) has been shown to be strongly responsive to long-term ethanol consumption, especially in the basal ganglia and the hippocampus. 30 We found a decrease in mRNA levels for two subunits of the sodium/potassium-specific ATPase, Atp1a2 and Atp1b2, a combination predominantly found in glia. 31 Together with a concomitant downregulation of glial fibrillary acidic protein (Gfap), these genes may reflect gliaspecific alterations in the amygdala. Studies of cerebellar tissue from AA rats have demonstrated downregulated Gfap expression after long-term ethanol consumption, 32 while a cDNA array study of cortical tissue from human alcoholics identified cytoskeleton-related genes, in particular myelin-associated genes and Gfap, as the most prominent dysregulations. 10 Whether these structural dysregulations contribute to function remains to be established.
Few genes were flagged as differentially expressed in more than one region. This suggests that, rather than reflecting global changes in brain function, altered gene expression conferring phenotypic differences between the lines may be confined to specific neuronal circuits. We hypothesized that the observed differences in basal gene expression may be caused by several independent mutations in the respective genes. A physical clustering of these mutations to a particular region of the rat genome would have pointed to an element of particular sensitivity to the selection pressure applied during breeding for ethanol preference. Contrary to this hypothesis, the affected genes appear to be scattered across the genome, and, with the exception of NPY, none of these genes is located near known quantitative trait loci (QTL) for alcohol preference or consumption in rats. 33, 34 Although, due to the relatively limited number of genes analysed, this conclusion must be regarded as preliminary. A true pathway or cluster assessment would require screens of at least ten times the present size, which is becoming feasible with the arrival of new generations of arrays for the rat genome. However, despite its limitation, the present study may be advantageous in identifying functional clusters, as seen by the findings in the Nc. Accumbens and amygdala. For legend see Table 2 .
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In summary, we report a number of differences in gene expression between the alcohol-preferring AA rat and its nonpreferring ANA counterpart, which precede any possible effects of ethanol, and thus may confer the innate alcohol preference in the AA line. Some of the detected differences point to novel candidate systems. The major phenotypic differences between the rat lines seem to be encoded by modest differences in brain gene expression, although the microarray analysis may underestimate their magnitude. 35 Quantitative real-time RT-PCR confirmation of differential preproNPY expression indicates that differences of this magnitude can be detected by the array analysis using the present experimental conditions, and, perhaps more importantly, the chosen statistical model. We conclude that gene expression profiling with oligonucleotide microarrays is a feasible strategy to detect previously unknown differences in basal gene expression between genetically determined phenotypes. This functional genomics approach is a putative tool in the search for novel targets for pharmacological treatment of alcoholism.
MATERIALS AND METHODS

Animals
Drug-naïve, ethanol-preferring AA (Alko, Alcohol, National Public Health Institute, Helsinki, Finland), ethanol-nonpreferring ANA (Alko, Non-Alcohol) and regular Wistar (BK Universal, Sollentuna, Sweden) male rats were included in the study (B300 g, n ¼ 12/group, standard housing conditions). Animals were killed by decapitation, the brains were snap frozen in À401C isopentane and kept in À701C until further dissection. The procedures were approved by Stockholm South Animal Ethics Committee (permit S81-84/98).
Tissue Preparation
Four brain regions were used in the microarray analysis: amygdala, cingulate cortex, hippocampus and Nc. Accumbens. Bilateral samples (10-60 mg depending on region) were obtained under a magnifying lens, using anatomical landmarks. 36 Amygdala, and hippocampus samples were prepared from a 2 mm thick coronal slice, taken in a Kopf brain slicer by placing the rostral blade on the caudal edge of the optic chiasm. For preparation of cingulate cortex and accumbens, the rostral blade was placed 4 mm rostral to this landmark, and a second 2 mm coronal slice was obtained. Cortical and hippocampal tissue was dissected out with a scalpel, while amygdala and accumbens tissue was obtained using a punch (2 mm diameter). Samples were weighed, and stored at À701C until RNA was prepared.
RNA Extraction and Purification
Total RNA was extracted with TRIzol reagent (Gibco BRL Life Technologies, Baltimore, MD, USA) followed by an RNeasy (Qiagen, Hilden, Germany) clean-up step according to the manufacturer's instructions. The yields of RNA were from about 6 to 30 mg depending on the region. The RNA was prepared individually, in parallel and in mixed order. All RNA samples showed A 260/280 ratios between 1.9 and 2.1. RNA integrity was determined using an Agilent 2100 Bioanalyzer (Agilent Technologies, CA, USA), and only material without signs of degradation was used.
Affymetrix Oligonucleotide Microarray Hybridization
Total RNA samples from nine animals per experimental group were chosen for microarray hybridization experiments. To reduce individual variation and chip numbers required, samples from each strain were pooled (three subjects/pool, 2-3 mg total RNA from each individual), yielding three independent pools from each strain for each region. Pooled RNAs were ethanol-precipitated together with 0.5 ml Pellet Paint (Novagen, Madison, WI, USA). Target preparation and hybridization were according to the manufacturer's technical manual (Affymetrix, Santa Clara, CA, USA). Briefly, double-stranded cDNA was synthesized using the Superscript Choice System (Gibco BRL, Life Technologies) with an HPLC-purified T7-(dT) 24 primer (Proligo, Boulder, CO, USA), starting with 6 mg of the pooled total RNA. cDNA was then purified with Phase Lock Gel (Eppendorf-5 Prime, Boulder, CO, USA) and phenol/chloroform (Ambion Inc., Austin, TX, USA) extraction, precipitated with ethanol (plus 0.5 ml Pellet Paint), and resuspended in RNase-free water. Biotinylated cRNA targets were in vitro transcribed using the RNA Transcript Labeling Kit (Enzo Diagnostics, Farmingdale, NY, USA). The synthesized cRNA was purified on an RNeasy column (Qiagen, Hilden, Germany), yielding 50-80 mg labeled cRNA/target. The cRNA was fragmented to an average size of 35-200 bases. In total, 5 mg of fragmented cRNA was used in the hybridization cocktail. Targets were hybridized for 14-16 h at 451C to oligonucleotide microarrays (Affymetrix Rat Neurobiology U34) containing probe sets for about 1000 genes. Chips were washed and stained on an automated fluidic station according to the procedure 2 protocol from Affymetrix, including antibody amplification. After scanning the arrays on a Hewlett-Packard Gene Array scanner, data were acquired with the Affymetrix MAS 5.0 software. Scanned images were visually inspected to be free of specks or scratches. Further quality assessment was carried out according to the following criteria: low noise (RawQ o 1.6-2.6), low background (bgo120), low 3 0 to 5 0 ratio of Gapd (ratioo2.3) and presence of control genes cre, BioD and BioC.
Statistical Analysis of Microarray Data and Data Mining
The Affymetrix MAS 5.0. scanner software provides individual probe readings. These were analysed with dChip 1.1 (http://www.dchip.org) as well as with the Affymetrix MAS 5.0 software. The dChip software, developed by Li and Wong, 37 fits a linear model across all chips. This allows the variance in signal for each probeset to be partitioned into a specific hybridization-related signal vs noise, and does so with increasing power as chips are added to the analysis. The approach also enables outliers to be flagged, providing a tool for quality control. Here, probe parameters were fitted to a larger data set consisting of the chips of the presented study, as well as other experiments carried out under identical conditions, for a total of 47 RN U34 array experiments performed on rat forebrain tissue. Maximum array probe sets outlier accepted was 5%. On the basis of this criterion four chips had to be excluded from the study.
Two parameters were used for the analysis of expression data: probability of transcript detection and estimates of transcript abundance. Calculation of the probability of transcript detection was based on the MAS 5.0 (which tests specificity of the PM-MM pair), while the estimates of transcript abundance are based on dChip's multichip algorithm (which uses only PM values).
Assessment of region-specific gene expression
The signal from a probe set was accounted as present in a particular region if it was flagged 'present' or 'marginally present' by MAS 5.0 on at least six of the eight arrays of that region, or on all chips of one rat line (these calls are based on a probability of detection of Po0.04, and 0.04rPo 0.06, respectively). A probe set was scored as absent for a region if it was flagged 'absent' by MAS 5.0 on all chips of that region (based on probability of detection was P40.06). The signal intensity threshold for an absent call (P40.06 probability of detection) varies considerably (min-max: 39-4597, dChip estimates) and is specific for each probe set. Additionally, there is region-to-region variation in the mean signal estimate of the absent calls. In order to ensure clear distinction between region-based absent and present calls, a signal was only called region-specific if the signal estimate in the region with the present call was at least by 50% above any region with an absent call. Furthermore, in cases where the signal was called present in two or more regions we tested for highly enriched gene expression defined as signal estimates at least two-fold above the levels of the other regions with a present call.
